Bladder preservation for localized muscle-invasive bladder cancer: The survival impact of local utilization rates of definitive radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 2, 2012, Pages

  Kozak, Kevin R ^a   Hamidi, Maryam ^a   Manning, Matthew ^b   Moody, John S ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Moses Cone Regional Cancer Center   (United States)

Author keywords

Bladder cancer; Chemoradiation; Organ preservation; SEER

Indexed keywords

BLADDER CANCERS; CHEMORADIATION; CONFIDENCE INTERVAL; COX MODEL; DEFINITIVE RADIOTHERAPY; GEOGRAPHIC LOCATION; HAZARD RATIO; INITIAL TREATMENT; KAPLAN-MEIER; LARGE SHIFTS; LOCAL MANAGEMENT; MEDIAN SURVIVAL; MULTI VARIABLES; MULTI VARIATE ANALYSIS; MULTIPLE FACTORS; ORGAN PRESERVATION; OVERALL SURVIVAL; PRESERVATION STRATEGIES; SEER; SURGICAL RESECTION; TUMOR GRADES; UTILIZATION RATES;

DISEASES; MUSCLE; SURGERY; TUMORS;

RADIOTHERAPY;

ADULT; AGED; ASIAN; BLADDER CANCER; CANCER GRADING; CANCER REGISTRY; CANCER SURVIVAL; CAUCASIAN; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEGRO; ORGAN PRESERVATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PACIFIC ISLANDER; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE ADENOCARCINOMA; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; UNITED STATES;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; ORGAN SPARING TREATMENTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84861101373     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.12.038     Document Type: Conference Paper

References (32)

1. A. Jemal, R. Siegel, and J. Xu Cancer statistics CA Cancer J Clin 60 5 2010 Sep-Oct 277 300
2. D.S. Kaufman, W.U. Shipley, and A.S. Feldman Bladder cancer Lancet 374 2009 239 249
3. J.E. Gschwend, W.R. Fair, and J. Vieweg Radical cystectomy for invasive bladder cancer: Contemporary results and remaining controversies Eur Urol 38 2000 121 130 (Pubitemid 30452312)
4. M.D. Shelley, J. Barber, and T. Wilt Surgery versus radiotherapy for muscle invasive bladder cancer Cochrane Database Syst Rev 2002 CD002079
5. J.P. Stein, G. Lieskovsky, and R. Cote Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients J Clin Oncol 19 2001 666 675 (Pubitemid 32120143)
6. M.K. Gospodarowicz, N.V. Hawkins, and G.A. Rawlings Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: Failure analysis J Urol 142 1989 1448 1453
7. H. Mameghan, R. Fisher, and J. Mameghan Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder Int J Radiat Oncol Biol Phys 31 1995 247 254
8. A. Sell, A. Jakobsen, and B. Nerstrom Treatment of advanced bladder cancer category T2 T3 and T4a. A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. DAVECA protocol 8201. Danish Vesical Cancer Group Scand J Urol Nephrol Suppl 138 1991 193 201
9. Neoadjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis Lancet 361 2003 1927 1934
10. M.S. Zaghloul Adjuvant and neoadjuvant radiotherapy for bladder cancer: Revisited Future Oncol 6 2010 1177 1191
11. E.W. Gerharz, A. Mansson, and S. Hunt Quality of life after cystectomy and urinary diversion: an evidence based analysis J Urol 174 2005 1729 1736 (Pubitemid 41546923)
12. L. Henningsohn, K. Steven, and E.B. Kallestrup Distressful symptoms and well-being after radical cystectomy and orthotopic bladder substitution compared with a matched control population J Urol 168 2002 168 174 (Pubitemid 34640808)
13. W.U. Shipley, D.S. Kaufman, and W.J. Tester Overview of bladder cancer trials in the Radiation Therapy Oncology Group Cancer 97 2003 2115 2119 (Pubitemid 36397252)
14. C. Rodel, C. Weiss, and R. Sauer Trimodality treatment and selective organ preservation for bladder cancer J Clin Oncol 24 2006 5536 5544 (Pubitemid 46631334)
15. G. Dalbagni, E. Genega, and M. Hashibe Cystectomy for bladder cancer: A contemporary series J Urol 165 2001 1111 1116 (Pubitemid 32210214)
16. H.B. Grossman, R.B. Natale, and C.M. Tangen Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 2003 859 866 (Pubitemid 37025405)
17. R.E. Hautmann, J.E. Gschwend, and R.C. de Petriconi Cystectomy for transitional cell carcinoma of the bladder: Results of a surgery only series in the neobladder era J Urol 176 2006 486 492 (Pubitemid 43927871)
18. C. Rodel, G.G. Grabenbauer, and R. Kuhn Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results J Clin Oncol 20 2002 3061 3071 (Pubitemid 34791095)
19. W.U. Shipley, K.A. Winter, and D.S. Kaufman Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: Initial results of Radiation Therapy Oncology Group 89-03 J Clin Oncol 16 1998 3576 3583 (Pubitemid 28506771)
20. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEERStat Database: Incidence - SEER 17 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2008 Sub (1973-2006 varying) - Linked To County Attributes - Total U.S., 1969-2006 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission. Available at www.seer.cancer.gov. Accessed March 2, 2010.
21. J. Wooldridge Introductory econometrics: A modern approach 2000 South-Western College Publishing Cincinatti, OH
22. T.A. Stukel, E.S. Fisher, and D.E. Wennberg Analysis of observational studies in the presence of treatment selection bias: Effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods JAMA 297 2007 278 285 (Pubitemid 46143305)
23. A.L. Zietman, D. Sacco, and U. Skowronski Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: Results of a urodynamic and quality of life study on long-term survivors J Urol 170 2003 1772 1776 (Pubitemid 37254925)
24. J.A. Efstathiou, K. Bae, and W.U. Shipley Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06 J Clin Oncol 27 2009 4055 4061
25. L. Henningsohn, H. Wijkstrom, and P.W. Dickman Distressful symptoms after radical radiotherapy for urinary bladder cancer Radiother Oncol 62 2002 215 225 (Pubitemid 34286455)
26. N.P. Munro, S.K. Sundaram, and P.M. Weston A 10-year retrospective review of a nonrandomized cohort of 458 patients undergoing radical radiotherapy or cystectomy in Yorkshire, UK Int J Radiat Oncol Biol Phys 77 2010 119 124
27. C.L. Amling, J.B. Thrasher, and H.A. Frazier Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder J Urol 151 1994 31 36 (Pubitemid 24046930)
28. H.A. Frazier, J.E. Robertson, and R.K. Dodge The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate Cancer 71 1993 3993 4001 (Pubitemid 23172983)
29. M.A. Ghoneim, M.M. el-Mekresh, and M.A. el-Baz Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases J Urol 158 1997 393 399 (Pubitemid 27327674)
30. C.M. Coppin, M.K. Gospodarowicz, and K. James Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 14 1996 2901 2907 (Pubitemid 26371447)
31. R.A. Huddart, E. Hall, and R. Lewis Life and death of SPARE (selective bladder preservation against radical excision): Reflections on why the SPARE trial closed BJU Int 106 2010 753 755
32. N. Shahab Bladder preservation trial: Radiation Therapy Oncology Group 89-03 J Clin Oncol 17 1999 1327 1328 (Pubitemid 29162962)